Cytosorbents News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

22.07.20	Stock Alert: Cytosorbents Corporation Spikes 10% (RTTNews)
31.05.20	Cytosorbents-Aktie: Experten empfehlen Cytosorbents im Mai mehrheitlich zum Kauf (finanzen.net)
04.05.20	Ausblick: Cytosorbents stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net)
13.04.20	Stock Alert: CytoSorbents Up 30% On FDA's Approval To Use CytoSorb For COVID-19 (RTTNews)
13.04.20	CytoSorbents: FDA Grants EUA Of CytoSorb In Patients With COVID-19 Infection (RTTNews)
25.03.20	Stock Alert: Cytosorbents Shares Up 36% In Pre-Market (RTTNews)
04.03.20	Ausblick: Cytosorbents gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net)
02.03.20	Stock Alert: Cytosorbents Corp. (CTSO) (RTTNews)
04.08.19	Ausblick: Cytosorbents stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
05.05.19	Ausblick: Cytosorbents stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net)
05.03.19	Ausblick: Cytosorbents zieht Bilanz zum abgelaufenen Quartal (finanzen.net)
04.11.18	Ausblick: Cytosorbents stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
12.06.18	CytoSorbents Officially Opens New U.S. CytoSorb Manufacturing Facility (PR Newswire)
04.06.18	CytoSorbents to Present at the Jefferies 2018 Global Healthcare Conference (PR Newswire)
21.05.18	CytoSorbents to Present at the 19th Annual B. Riley FBR Investor Conference (PR Newswire)
14.05.18	CytoSorb® Adds Bilirubin and Myoglobin Reduction to European Union Approved Indications for Use (PR Newswire)
08.05.18	CytoSorbents Reports Strong First Quarter 2018 Financial Results (PR Newswire)
02.05.18	CytoSorbents to Report Q1 2018 Operating and Financial Results (PR Newswire)
01.05.18	OppenheimerFunds Announces Factor Derby for Charity (PR Newswire)
26.04.18	CheapOair.com Shares Top Hacks for Finding Cheap Airfare (PR Newswire)
24.04.18	CytoSorbents Enrolls First Patient into Pivotal U.S. REFRESH 2-AKI Trial Using CytoSorb® During Complex Cardiac Surgery (PR Newswire)
09.04.18	CytoSorbents to Meet With European Investors at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo and in Meetings in Frankfurt, Geneva and Zurich (PR Newswire)
06.04.18	BLANCO launches the innovative PRECISION® R0 Farmhouse sink crafted of its groundbreaking DURINOX® material (PR Newswire)
04.04.18	CytoSorbents Refinances Existing Debt with New $15 Million Debt Facility with Bridge Bank (PR Newswire)
28.03.18	CytoSorbents Reports on the Successful 5th International CytoSorb Users Meeting and 38th ISICEM Critical Care Conference (PR Newswire)
12.03.18	CytoSorbents to Present at the 38th Annual Cowen Healthcare Conference (PR Newswire)
08.03.18	CytoSorbents Achieves Record Revenue and Product Sales Growth in 2017 (PR Newswire)
01.03.18	CytoSorbents to Report Fiscal 2017 Operating and Financial Results (PR Newswire)
26.02.18	CytoSorbents to Participate at the BTIG Healthcare Conference (PR Newswire)
15.02.18	CytoSorbents Expands Its Partnership with Biocon to Launch CytoSorb® in Malaysia (PR Newswire)
06.02.18	CytoSorbents to Present at the 20th Annual BIO CEO & Investor Conference (PR Newswire)
01.02.18	New Study Demonstrates Improved Hemodynamic Stability After Heart Transplant Surgery using Intraoperative CytoSorb® Blood Purification (PR Newswire)
19.01.18	ProfNet Experts Available on Travel, Eating Clean, Reducing Stress, More (PR Newswire)
08.01.18	CytoSorbents Pre-Announces Preliminary Fourth Quarter and Full Year 2017 Results and Issues Stockholder Letter (PR Newswire)
03.01.18	CytoSorbents To Provide Corporate Update at Biotech Showcase 2018 (PR Newswire)
21.12.17	CytoSorbents Achieves Key Milestone with FDA Approval of the U.S. REFRESH 2 Pivotal Cardiac Surgery Trial IDE Application (PR Newswire)
20.12.17	Cohen & Steers Infrastructure Fund, Inc. (UTF) Declares Year-End Capital Gain Distribution (PR Newswire)
19.12.17	CytoSorbents Receives $676,739 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program (PR Newswire)
11.12.17	German Federal Ministry of Education and Research to Fund the CytoSorb® Endocarditis REMOVE Trial (PR Newswire)
29.11.17	CytoSorbents to Present at the LD Micro Main Event Investor Conference (PR Newswire)
09.11.17	CytoSorbents Continues Strong Trajectory of Growth in the Third Quarter 2017 (PR Newswire)
09.11.17	CytoSorbents Recognized on Deloitte's 2017 Technology Fast 500™ as One of the Fastest Growing Companies in North America (PR Newswire)
02.11.17	CytoSorbents to Report Q3 2017 Operating and Financial Results (PR Newswire)
01.11.17	CytoSorbents Awarded Approximately $1.0 Million in Phase II SBIR Funding to Optimize New Treatment Approaches for Severe Hyperkalemia (PR Newswire)
19.10.17	CytoSorb® Usage During Valve Replacement Surgery for Infective Endocarditis Helps Stabilize Patients and May Improve Survival (PR Newswire)
10.10.17	CytoSorbents to Present at the 2017 BIO Investor Forum (PR Newswire)
26.09.17	CytoSorbents Introduces the CytoSorb Therapeutic ECMO™ Kit at the 2017 European Society of Intensive Care Medicine Congress (PR Newswire)
25.09.17	Key Clinical Study Showing Reversal of Refractory Septic Shock in Patients Treated with CytoSorb® (PR Newswire)
14.09.17	World Sepsis Day 2017: CytoSorbents Sponsors the Sepsis Update 2017 Congress and Sepsis Heroes Ceremony (PR Newswire)
11.09.17	Aferetica and CytoSorbents Partner to Enhance the Success of Solid Organ Transplantation (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Cytosorbents Corp

Aktien Top/Flop

Meistgelesene Nachrichten